BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21687654)

  • 1. Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease.
    Oppenheimer M; Valenciano AL; Sobrado P
    Enzyme Res; 2011; 2011():415976. PubMed ID: 21687654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
    Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
    J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.
    Oppenheimer M; Valenciano AL; Kizjakina K; Qi J; Sobrado P
    PLoS One; 2012; 7(3):e32918. PubMed ID: 22448231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening.
    Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA
    Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UDP-galactopyranose mutase in nematodes.
    Wesener DA; May JF; Huffman EM; Kiessling LL
    Biochemistry; 2013 Jun; 52(25):4391-8. PubMed ID: 23697711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
    Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
    Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase.
    Ma L; Salas O; Bowler K; Bar-Peled M; Sharon A
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the UDP-glucose-4-epimerase required for galactofuranose biosynthesis and galactose metabolism in
    Park J; Tefsen B; Arentshorst M; Lagendijk E; van den Hondel CA; van Die I; Ram AF
    Fungal Biol Biotechnol; 2014; 1():6. PubMed ID: 28955448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and biology of galactofuranose-containing polysaccharides.
    Richards MR; Lowary TL
    Chembiochem; 2009 Aug; 10(12):1920-38. PubMed ID: 19591187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations.
    Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM
    J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.
    Dhatwalia R; Singh H; Oppenheimer M; Sobrado P; Tanner JJ
    Biochemistry; 2012 Jun; 51(24):4968-79. PubMed ID: 22646091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, mechanism, and dynamics of UDP-galactopyranose mutase.
    Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P
    Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence Polarization Binding Assay for Aspergillus fumigatus Virulence Factor UDP-Galactopyranose Mutase.
    Qi J; Oppenheimer M; Sobrado P
    Enzyme Res; 2011; 2011():513905. PubMed ID: 21876791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis.
    Fonseca IO; Kizjakina K; Sobrado P
    Arch Biochem Biophys; 2013 Oct; 538(2):103-10. PubMed ID: 24012809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
    Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
    Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the phosphoglucomutase of Trypanosoma cruzi and functional complementation of a Saccharomyces cerevisiae PGM null mutant.
    Penha LL; Mendonça-Previato L; Previato JO; Scharfstein J; Heise N; Lima AP
    Glycobiology; 2005 Dec; 15(12):1359-67. PubMed ID: 16037487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
    Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
    J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QM/MM molecular dynamics study of the galactopyranose → galactofuranose reaction catalysed by Trypanosoma cruzi UDP-galactopyranose mutase.
    Pierdominici-Sottile G; Cossio Pérez R; Galindo JF; Palma J
    PLoS One; 2014; 9(10):e109559. PubMed ID: 25299056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.